Loblaw Companies Limited · TSX:L
Loblaw Companies — Q2 2016 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, Jul 27, 2016
Slide 1: Q2 2016 Supplementary Slides
Q2 2016 Supplementary Slides July 27, 2016 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Loblaw – Q2 2016
Key Financial Metrics – Loblaw – Q2 2016 Consolidated Revenue $10,731M,+1.9% Adjusted EBITDA $924M, +7.8% Adjusted Diluted Earnings Per Common Share $1.01, +20.2% Net Synergies $83M, incremental $30M ($300M Target achieved) Free Cash Flow +$432M QTD Capex ($) $214M QTD 3
Slide 4: Key Retail Metrics – Q2 2016
Key Retail Metrics – Q2 2016 Total Retail Revenue $10,494M, +1.7% Retail Revenue - Food Retail $7,718M,+1.2% Retail Revenue - Drug Retail $2,776M,+3.2% Retail Adjusted Gross Profit & Margin $2,751M; 26.4% (+10bps to PY) (Excluding the impact of the consolidation of franchises) (As Reported: $2,826 m
Slide 5: Key Operational Metrics – Q2 2016 – Food Retail
Key Operational Metrics – Q2 2016 — Food Retail Food Retail Same-Store Sales Growth +0.7%; +1.7% excluding the negative impact of Easter (ex.Gas Bar -30bps) Basket Size Positive Traffic Flat (excluding the negative impact of Easter) Internal Inflation Loblaw slightly lower than Q2 Food CPI of 1.8% L
Slide 6: Key Operational Metrics – Q2 2016 – Drug Retail
Key Operational Metrics – Q2 2016 – Drug Retail Pharmacy Sales $1,324M, +3.9% Pharmacy SSS +3.6% # Rx Dispensed (Rx Count) +3.6% (+3.3% on same-store sales basis) Average Rx Value +0.4% Front Store Sales $1,452 M, + 2.6% Front Store SSS +4.3% Loyalty (Optimum) Over 10 million active members 6